Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation.

ABSTRACT: BACKGROUND:Combined 'hybrid' thoracoscopic and percutaneous atrial fibrillation (AF) ablation is a strategy used to treat AF in patients with therapy-resistant symptomatic AF. We aimed to study efficacy and safety of single-stage hybrid AF ablation in patients with symptomatic persistent AF, or paroxysmal AF with failed endocardial ablation, and assess determinants of success and quality of life. METHODS:We included consecutive patients undergoing single-stage hybrid AF ablation. First, we performed epicardial ablation, via thoracoscopic access, to isolate the pulmonary veins and superior caval vein and to create a posterior left atrial box. Thereafter, isolation was assessed endocardially and complementary endocardial ablation was performed, followed by cavotricuspid isthmus ablation. Eff

SUBMITTER: Al-Jazairi MIH 

PROVIDER: S-EPMC6393682 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature